A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common ...

Scientists in The Wistar Institute lab of David B. Weiner, Ph.D., have described a next-generation vaccination technology ...

A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common chronic diseases like heart disease, diabetes, and cancer.

Nanotechnology offers a next-gen solution to plant genome editing challenges by enabling precise, efficient delivery of CRISPR, RNA, and DNA tools using nanoparticles like AuNPs, CNTs, and lipid ...

Head and neck cancers often begin in the mouth, throat, or voice box. They're among the most common cancers in the world, ...

Another company looking to initiate clinical trials with an epigenetic-editor-based treatment for hepatitis is nChroma Bio.

DPD simplifies DNA strands and nanoparticles into bead-like units, enabling the study of self-assembly over extended timescales and larger length scales than traditional molecular dynamics.

PLC (AIM: 4BB) (“4basebio”), a company which develops and commercializes the large-scale manufacture of synthetic DNA as well as nanoparticle delivery solutions, today announced that it has received ...

Nonetheless, scientists know that silver nanoparticles can damage cell membranes, block the production of ATP, fragment DNA, and more—all of which could destroy cancer cells. Although these ...

A new process that transports DNA into cells using tiny fat-based carriers called lipid nanoparticles (LNPs) developed by researchers at the Perelman School of Medicine at the University of ...